Thu, Aug 28, 2014, 11:08 AM EDT - U.S. Markets close in 4 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

Rosetta Genomics, Ltd. Message Board

  • mrbub23@sbcglobal.net mrbub23 Nov 21, 2013 1:35 PM Flag

    NOPE! PRICE MOVEMENT DUE TO LECTURE AMONG BIG TIME DOCTORS/ ONCOLOGISTS.

    Ceo & board member comments....
    mirna is misunderstood and quite a unknown...
    intriging to those that first learn and begin to understand the technology.
    its 21st century cutting edge technology
    just now being implemented and monetized.
    collaborations continue.
    sales will ramp.
    patents protect our value vault!
    2015 will be the year of mirna explosive growth...
    2014 will be huge year for mirna growth.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • looks like at this point, there is no much believe in this . When it will be translated into sustained price movement ( upwards ) , then we can say , it's recognized by the public.

      Sentiment: Buy

      • 1 Reply to ilyak98
      • Up moves today on heavy volume, pull backs on much lighter volume. What's not to like? As to fundamentals, no argument from me that ROSG has a long way to go to convince the investing community that the company has solid products with a profitable business model. Blunders by management in the past have not helped. However, the news has been getting continually better the past six months or so, and if it continues to be positive, we will see a strong turnaround next year. Investing in this company is not meant for quick gains, as it will most likely burn traders on either end eventually. It is a long-term process that will either pay off extremely well in a few years, or crash and burn if the products are not genuinely helping in the fight against cancer.

 
ROSG
3.65-0.06(-1.62%)10:58 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.